𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1

✍ Scribed by Li-Min Xia; Wen-Jie Huang; Bo Wang; Mei Liu; Qiong Zhang; Wei Yan; Qian Zhu; Min Luo; Zhen-Zhen Zhou; De-An Tian


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
385 KB
Volume
106
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The proliferation‐specific Forkhead box M1 (FoxM1) transcription factor is overexpressed in cancer cells and acts as an important regulator of cancer cell growth and survival. Here, we show the molecular mechanisms by which hypoxia regulate FoxM1 expression in cancer cells. When cells were subjected to hypoxia (1% O~2~), the mRNA and protein levels of FoxM1 had a significant increase in cancer cells (HepG2, MCF‐7, and HeLa). Such increase was due to the direct binding of hypoxia‐inducible factor 1 (HIF‐1) to the HIF‐1 binding sites in the FoxM1 promoter. By deletion and mutation assays, we demonstrated that the HIF1‐1 and HIF1‐3/4 binding sites on the FoxM1 promoter were essential for transcriptional activation of FoxM1 by hypoxia. We also demonstrated that HIF‐1α directly bound to the promoter of FoxM1 and the binding was specific, as revealed by HIF‐1 binding/competition assay and chromatin immunoprecipitation assay. Consequently, the up‐regulation of FoxM1 accelerated the growth of hypoxic cancer cells by decreasing nuclear levels of p21 and increasing expression of cyclin B1 and cyclin D1. These findings provide a new insight into how tumor cells overcome hypoxic stress and survive, and also disclose a new regulatory mechanism of FoxM1 expression in tumor cells. J. Cell. Biochem. 106: 247–256, 2009. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Transcriptional upregulation of HSP70-2
✍ Wen-Jie Huang; Li-Min Xia; Fan Zhu; Bo Huang; Chun Zhou; Hui-Fen Zhu; Bo Wang; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 481 KB

## Abstract Heat shock protein 70‐2 (HSP70‐2) can be expressed by cancer cells and act as an important regulator of cancer cell growth and survival. Here, we show the molecular mechanisms by which hypoxia regulate HSP70‐2 expression in cancer cells. When cells were subjected to hypoxia (1% O~2~), t

NERF2, a member of the Ets family of tra
✍ Rial A. Christensen; Koshi Fujikawa; Rebecca Madore; Peter Oettgen; Lyuba Vartic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

## Abstract Vascular endothelial growth factor (VEGF) and angiopoietins regulate endothelial cell survival and migration and are essential for angiogenesis. Considerable progress has been made towards understanding hypoxia‐mediated regulation of VEGF and its receptors. In contrast, little is known

The angiopoietin-2 gene of endothelial c
✍ Marie-Pierre Simon; Roselyne Tournaire; Jacques Pouyssegur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

## Abstract Angiopoietins are ligands of the endothelial cell tyrosine kinase receptor Tie2. Angiopoietin‐1 (Ang‐1) is widely expressed in human normal adult tissues and promotes blood vessel maturation and stabilization by inducing Tie2 receptor phosphorylation. In contrast, the antagonistic ligan

Antiangiogenic activity of genistein in
✍ Peter Büchler; Howard A. Reber; Markus W. Büchler; Helmut Friess; Robert S. Lave 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

## Abstract ## BACKGROUND Previous reports indicate that Genistein, a naturally occurring isoflavonoid, exhibits strong antiangiogenic activity. The underlying mechanism of inhibition, however, remains unclear. Among the biologic effects of Genistein are the inhibition of tyrosine kinases and the

TGF-β-induced expression of tissue inhib
✍ Hamid Yaqoob Qureshi; Judith Sylvester; Mohammed El Mabrouk; Muhammad Zafarullah 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

## Abstract Transforming growth factor (TGF‐β1) is a potent inducer of chondrogenesis and stimulant of cartilage extracellular matrix (ECM) synthesis. Tissue inhibitor of metalloproteinases‐3 (TIMP‐3) is located in ECM and is the major inhibitor of matrix metalloproteinases (MMPs) and aggrecanase,